Recommendations for improving the quality of reporting clinical electrochemotherapy studies based on qualitative systematic review

1Mali B, Jarm T, Snoj M, Sersa G, Miklavcic D. Antitumor effectiveness of electrochemotherapy: A systematic review and meta-analysis. EJSO 2013; 39: 4–16.MaliBJarmTSnojMSersaGMiklavcicDAntitumor effectiveness of electrochemotherapy: A systematic review and meta-analysisEJSO20133941610.1016/j.ejso.2012.08.016Search in Google Scholar

2Spratt DE, Spratt EAG, Wu SH, DeRosa A, Lee NY, Lacouture ME, et al. Efficacy of skin-directed therapy for cutaneous metastases from advanced cancer: A meta-analysis. J Clin Oncol 2014; 32: 3144–55.SprattDESprattEAGWuSHDeRosaALeeNYLacoutureMEEfficacy of skin-directed therapy for cutaneous metastases from advanced cancer: A meta-analysisJ Clin Oncol20143231445510.1200/JCO.2014.55.4634Search in Google Scholar

3Neumann E, Schaefer-Ridder M, Wang Y, Hofschneider PH. Gene transfer into mouse lyoma cells by electroporation in high electric fields. EMBO J 1982; 1: 841–5.NeumannESchaefer-RidderMWangYHofschneiderPHGene transfer into mouse lyoma cells by electroporation in high electric fieldsEMBO J19821841510.1002/j.1460-2075.1982.tb01257.xSearch in Google Scholar

4Glass LF, Pepine ML, Fenske NA, Jaroszeski M, Reintgen DS, Heller R. Bleomycin-mediated electrochemotherapy of metastatic melanoma. Arch Dermatol 1996; 132: 1353–7.GlassLFPepineMLFenskeNAJaroszeskiMReintgenDSHellerRBleomycin-mediated electrochemotherapy of metastatic melanomaArch Dermatol19961321353710.1001/archderm.1996.03890350095015Search in Google Scholar

5Heller R, Jaroszeski MJ, Glass LF, Messina JL, Rapaport DP, DeConti RC, et al. Phase I/II trial for the treatment of cutaneous and subcutaneous tumors using electrochemotherapy. Cancer 1996; 77: 964–71.HellerRJaroszeskiMJGlassLFMessinaJLRapaportDPDeContiRCPhase I/II trial for the treatment of cutaneous and subcutaneous tumors using electrochemotherapyCancer1996779647110.1002/(SICI)1097-0142(19960301)77:5<964::AID-CNCR24>3.0.CO;2-0Search in Google Scholar

6Mir LM, Belehradek M, Domenge C, Orlowski S, Poddevin B, Belehradek J Jr., et al. Electrochemotherapy, a new antitumor treatment: first clinical trial. C R Acad Sci III 1991; 313: 613–18.MirLMBelehradekMDomengeCOrlowskiSPoddevinBBelehradekJJr.Electrochemotherapy, a new antitumor treatment: first clinical trialC R Acad Sci III199131361318Search in Google Scholar

7Mir LM, Orlowski S, Belehradek J Jr., Paoletti C. Electrochemotherapy potentiation of antitumour effect of bleomycin by local electric pulses. Eur J Cancer 1991; 27: 68–72.MirLMOrlowskiSBelehradekJJr.PaolettiCElectrochemotherapy potentiation of antitumour effect of bleomycin by local electric pulsesEur J Cancer199127687210.1016/0277-5379(91)90064-KSearch in Google Scholar

8Giraud P, Bachaud JM, Teissie J, Rols MP. Effects of electrochemotherapy on cutaneous metastases of human malignant melanoma. Int J Rad Oncol Biol Phys 1996; 36: 1285.GiraudPBachaudJMTeissieJRolsMPEffects of electrochemotherapy on cutaneous metastases of human malignant melanomaInt J Rad Oncol Biol Phys199636128510.1016/S0360-3016(97)81378-8Search in Google Scholar

9Rols MP, Bachaud JM, Giraud P, Chevreau C, Roche H, Teissie J. Electrochemotherapy of cutaneous metastases in malignant melanoma. Melanoma Res 2000; 10: 468–74.RolsMPBachaudJMGiraudPChevreauCRocheHTeissieJElectrochemotherapy of cutaneous metastases in malignant melanomaMelanoma Res2000104687410.1097/00008390-200010000-00009Search in Google Scholar

10Mir LM, Glass LF, Sersa G, Teissie J, Domenge C, Miklavcic D, et al. Effective treatment of cutaneous and subcutaneous malignant tumours by electro-chemotherapy. Brit J Cancer 1998; 77: 2336–42.MirLMGlassLFSersaGTeissieJDomengeCMiklavcicDEffective treatment of cutaneous and subcutaneous malignant tumours by electro-chemotherapyBrit J Cancer19987723364210.1038/bjc.1998.388Search in Google Scholar

11Glass LF, Fenske NA, Jaroszeski M, Perrott R, Harvey DT, Reintgen DS, et al. Bleomycin-mediated electrochemotherapy of basal cell carcinoma. J Am Acad Dermatol 1996; 34: 82–6.GlassLFFenskeNAJaroszeskiMPerrottRHarveyDTReintgenDSBleomycin-mediated electrochemotherapy of basal cell carcinomaJ Am Acad Dermatol19963482610.1016/S0190-9622(96)90838-5Search in Google Scholar

12Heller R, Jaroszeski MJ, Reintgen DS, Puleo CA, DeConti RC, Gilbert RA, et al. Treatment of cutaneous and subcutaneous tumors with electrochemo-therapy using intralesional bleomycin. Cancer 1998; 83: 148–57.HellerRJaroszeskiMJReintgenDSPuleoCADeContiRCGilbertRATreatment of cutaneous and subcutaneous tumors with electrochemo-therapy using intralesional bleomycinCancer1998831485710.1002/(SICI)1097-0142(19980701)83:1<148::AID-CNCR20>3.0.CO;2-WSearch in Google Scholar

13Belehradek M, Domenge C, Luboinski B, Orlowski S, Belehradek J Jr., Mir LM. Electrochemotherapy, a new antitumor treatment. First clinical phase I-II trial. Cancer 1993; 72: 3694-700.BelehradekMDomengeCLuboinskiBOrlowskiSBelehradekJJr.MirLMElectrochemotherapy, a new antitumor treatment. First clinical phase I-II trialCancer199372369470010.1002/1097-0142(19931215)72:12<3694::AID-CNCR2820721222>3.0.CO;2-2Search in Google Scholar

14Eisenstein M. A shock to the system. Nat Meth 2006; 3: 66.EisensteinMA shock to the systemNat Meth200636610.1038/nmeth0106-66Search in Google Scholar

15Kotnik T, Frey W, Sack M, Haberl Meglič S, Peterka M, Miklavčič D. Electroporation-based applications in biotechnology. Trends Biotechnol 2015; 33: 480–8.KotnikTFreyWSackMHaberl MegličSPeterkaMMiklavčičDElectroporation-based applications in biotechnologyTrends Biotechnol201533480810.1016/j.tibtech.2015.06.002Search in Google Scholar

16Sersa G, Miklavcic D, Cemazar M, Rudolf Z, Pucihar G, Snoj M. Electrochemotherapy in treatment of tumours. EJSO 2008; 34: 232–40.SersaGMiklavcicDCemazarMRudolfZPuciharGSnojMElectrochemotherapy in treatment of tumoursEJSO2008342324010.1016/j.ejso.2007.05.016Search in Google Scholar

17Miklavcic D, Mali B, Kos B, Heller R, Sersa G. Electrochemotherapy: from the drawing board into medical practice. BioMedical Engineering OnLine 2014; 13: 29.MiklavcicDMaliBKosBHellerRSersaGElectrochemotherapy: from the drawing board into medical practiceBioMedical Engineering OnLine2014132910.1186/1475-925X-13-29Search in Google Scholar

18Bureau MF, Gehl J, Deleuze V, Mir LM, Scherman D. Importance of association between permeabilization and electrophoretic forces for intramuscular DNA electrotransfer. Biochim Biophys Acta 2000; 1474: 353–9.BureauMFGehlJDeleuzeVMirLMSchermanDImportance of association between permeabilization and electrophoretic forces for intramuscular DNA electrotransferBiochim Biophys Acta20001474353910.1016/S0304-4165(00)00028-3Search in Google Scholar

19Quaglino P, Mortera C, Osella-Abate S, Barberis M, Illengo M, Rissone M, et al. Electrochemotherapy with intravenous bleomycin in the local treatment of skin melanoma metastases. Ann Surg Oncol 2008; 15: 2215–22.QuaglinoPMorteraCOsella-AbateSBarberisMIllengoMRissoneMElectrochemotherapy with intravenous bleomycin in the local treatment of skin melanoma metastasesAnn Surg Oncol20081522152210.1245/s10434-008-9976-0Search in Google Scholar

20Campana LG, Valpione S, Falci C, Mocellin S, Basso M, Corti L, et al. The activity and safety of electrochemotherapy in persistent chest wall recurrence from breast cancer after mastectomy: a phase-II study. Breast Cancer Res Treat 2012; 134: 1169–78.CampanaLGValpioneSFalciCMocellinSBassoMCortiLThe activity and safety of electrochemotherapy in persistent chest wall recurrence from breast cancer after mastectomy: a phase-II studyBreast Cancer Res Treat201213411697810.1007/s10549-012-2095-4Search in Google Scholar

21Campana LG, Valpione S, Mocellin S, Sundararajan R, Granziera E, Sartore L, et al. Electrochemotherapy for disseminated superficial metastases from malignant melanoma. Brit J Surg 2012; 99: 821–30.CampanaLGValpioneSMocellinSSundararajanRGranzieraESartoreLElectrochemotherapy for disseminated superficial metastases from malignant melanomaBrit J Surg2012998213010.1002/bjs.8749Search in Google Scholar

22Matthiessen LW, Chalmers RL, Sainsbury DC, Veeramani S, Kessell G, Humphreys AC, et al. Management of cutaneous metastases using electro-chemotherapy. Acta Oncol 2011; 50: 621–9.MatthiessenLWChalmersRLSainsburyDCVeeramaniSKessellGHumphreysACManagement of cutaneous metastases using electro-chemotherapyActa Oncol201150621910.3109/0284186X.2011.573626313099721574833Search in Google Scholar

23Salwa SP, Bourke MG, Forde PF, O’Shaughnessy M, O’Sullivan ST, Kelly EJ, et al. Electrochemotherapy for the treatment of ocular basal cell carcinoma; a novel adjunct in the disease management. J Plast Reconstr Aesthet Surg 2014; 67: 403–6.SalwaSPBourkeMGFordePFO’ShaughnessyMO’SullivanSTKellyEJElectrochemotherapy for the treatment of ocular basal cell carcinoma; a novel adjunct in the disease managementJ Plast Reconstr Aesthet Surg201467403610.1016/j.bjps.2013.07.01923916385Search in Google Scholar

24Mir LM GJ, Sersa G, Collins CG, Garbay JR, Billard V, et al. Standard operating procedures of the electrochemotherapy: Instructions for the use of bleomycin or cisplatin administered either systemically or locally and electric pulses delivered by the Cliniporator by means of invasive or non-invasive electrodes. EJC Suppl 2006; 4: 14–25.Mir LMGJSersaGCollinsCGGarbayJRBillardVStandard operating procedures of the electrochemotherapy: Instructions for the use of bleomycin or cisplatin administered either systemically or locally and electric pulses delivered by the Cliniporator by means of invasive or non-invasive electrodesEJC Suppl20064142510.1016/j.ejcsup.2006.08.003Search in Google Scholar

25Miklavcic D, Snoj M, Zupanic A, Kos B, Cemazar M, Kropivnik M, et al. Towards treatment planning and treatment of deep-seated solid tumors by electrochemotherapy. BioMedical Engineering OnLine 2010; 9: 10.MiklavcicDSnojMZupanicAKosBCemazarMKropivnikMTowards treatment planning and treatment of deep-seated solid tumors by electrochemotherapyBioMedical Engineering OnLine201091010.1186/1475-925X-9-10284368420178589Search in Google Scholar

26Edhemovic I, Gadzijev EM, Brecelj E, Miklavcic D, Kos B, Zupanic A, et al. Electrochemotherapy: a new technological approach in treatment of metastases in the liver. Tecnol Cancer Res Treat 2011; 10: 475–85.EdhemovicIGadzijevEMBreceljEMiklavcicDKosBZupanicAElectrochemotherapy: a new technological approach in treatment of metastases in the liverTecnol Cancer Res Treat2011104758510.7785/tcrt.2012.500224452741421895032Search in Google Scholar

27Miklavcic D, Sersa G, Brecelj E, Gehl J, Soden D, Bianchi G, et al. Electrochemotherapy: technological advancements for efficient electroporation-based treatment of internal tumors. Med Biol Eng Comput 2012; 50: 1213–25.MiklavcicDSersaGBreceljEGehlJSodenDBianchiGElectrochemotherapy: technological advancements for efficient electroporation-based treatment of internal tumorsMed Biol Eng Comput20125012132510.1007/s11517-012-0991-8351469923179413Search in Google Scholar

28Soden D, Larkin J, Collins C, Piggott J, Morrissey A, Norman A, et al. The development of novel flexible electrode arrays for the electrochemotherapy of solid tumour tissue. (Potential for endoscopic treatment of inaccessible cancers). Conf Proc IEEE Eng Med Biol Soc 2004; 5: 3547–50.SodenDLarkinJCollinsCPiggottJMorrisseyANormanAThe development of novel flexible electrode arrays for the electrochemotherapy of solid tumour tissue. (Potential for endoscopic treatment of inaccessible cancers)Conf Proc IEEE Eng Med Biol Soc2004535475010.1109/IEMBS.2004.140399717271056Search in Google Scholar

29Edhemovic I, Brecelj E, Gasljevic G, Marolt Music M, Gorjup V, Mali B, et al. Intraoperative electrochemotherapy of colorectal liver metastases. J Surg Oncol 2014; 110: 320–7.EdhemovicIBreceljEGasljevicGMarolt MusicMGorjupVMaliBIntraoperative electrochemotherapy of colorectal liver metastasesJ Surg Oncol2014110320710.1002/jso.2362524782355Search in Google Scholar

30Journals unite for reproducibility. Nature 2014; 515: 7.Journals unite for reproducibilityNature2014515710.1038/515007a25373636Search in Google Scholar

31Miklavcic D. Network for development of electroporation-based technologies and treatments: COST TD1104. J Membrane Biol 2012; 245: 591–8.MiklavcicDNetwork for development of electroporation-based technologies and treatments: COST TD1104J Membrane Biol2012245591810.1007/s00232-012-9493-8346978822922776Search in Google Scholar

32Khan AA, Clover AJ. New guidelines for reporting observational studies and their implications for plastic surgery (STROBE). J Plast Reconstr Aesthet Surg 2009; 62: 155–6.KhanAACloverAJNew guidelines for reporting observational studies and their implications for plastic surgery (STROBE)J Plast Reconstr Aesthet Surg200962155610.1016/j.bjps.2008.09.00818976974Search in Google Scholar

33Al-Benna S, Clover J. The role of the journal impact factor: choosing the optimal source of peer-reviewed plastic surgery information. Plast Reconstr Surg 2007; 119: 755–6.Al-BennaSCloverJThe role of the journal impact factor: choosing the optimal source of peer-reviewed plastic surgery informationPlast Reconstr Surg2007119755610.1097/01.prs.0000247939.69221.5e17230130Search in Google Scholar

34Chang SM, Reynolds SL, Butowski N, Lamborn KR, Buckner JC, Kaplan RS, et al. GNOSIS: guidelines for neuro-oncology: standards for investigational studies-reporting of phase 1 and phase 2 clinical trials. Neuro Oncol 2005; 7: 425–34.ChangSMReynoldsSLButowskiNLambornKRBucknerJCKaplanRSGNOSIS: guidelines for neuro-oncology: standards for investigational studies-reporting of phase 1 and phase 2 clinical trialsNeuro Oncol200574253410.1215/S1152851705000554187172616212807Search in Google Scholar

35Trabulsi NH, Patakfalvi L, Nassif MO, Turcotte RE, Nichols A, Meguerditchian AN. Hyperthermic isolated limb perfusion for extremity soft tissue sarcomas: systematic review of clinical efficacy and quality assessment of reported trials. J Surg Oncol 2012; 106: 921–8.TrabulsiNHPatakfalviLNassifMOTurcotteRENicholsAMeguerditchianANHyperthermic isolated limb perfusion for extremity soft tissue sarcomas: systematic review of clinical efficacy and quality assessment of reported trialsJ Surg Oncol2012106921810.1002/jso.2320022806575Search in Google Scholar

36Mariani L, Marubini E. Content and quality of currently published phase II cancer trials. J Clin Oncol 2000; 18: 429–36.MarianiLMarubiniEContent and quality of currently published phase II cancer trialsJ Clin Oncol2000184293610.1200/JCO.2000.18.2.42910637259Search in Google Scholar

37Rotunno R, Marenco F, Ribero S, Calvieri S, Amerio P, Curatolo P, et al. Electrochemotherapy in non-melanoma head and neck skin cancers: a three centers experience and literature review. G Ital Dermatol Venereol 2015; in pressRotunnoRMarencoFRiberoSCalvieriSAmerioPCuratoloPElectrochemotherapy in non-melanoma head and neck skin cancers: a three centers experience and literature reviewG Ital Dermatol Venereol2015in pressSearch in Google Scholar

38Cabula C, Campana LG, Grilz G, Galuppo S, Bussone R, De Meo L, et al. Electrochemotherapy in the treatment of cutaneous metastases from breast cancer: A multicenter cohort analysis. Ann Surg Oncol 2015; 22 (Suppl 3): 442–50.CabulaCCampanaLGGrilzGGaluppoSBussoneRDe MeoLElectrochemotherapy in the treatment of cutaneous metastases from breast cancer: A multicenter cohort analysisAnn Surg Oncol201522(Suppl 3)4425010.1245/s10434-015-4779-6468655126242370Search in Google Scholar

39Mozzillo N, Simeone E, Benedetto L, Curvietto M, Giannarelli D, Gentilcore G, et al. Assessing a novel immuno-oncology-based combination therapy: Ipilimumab plus electrochemotherapy. Oncoimmunology 2015; 4(6): e108842.MozzilloNSimeoneEBenedettoLCurviettoMGiannarelliDGentilcoreGAssessing a novel immuno-oncology-based combination therapy: Ipilimumab plus electrochemotherapyOncoimmunology20154(6)e100884210.1080/2162402X.2015.1008842448575826155423Search in Google Scholar

40Landstrom FJ, Reizenstein J, Adamsson GB, Beckerath M, Moller C. Long-term follow-up in patients treated with curative electrochemotherapy for cancer in the oral cavity and oropharynx. Acta Otolaryngol 2015; 135: 1070–8.LandstromFJReizensteinJAdamssonGBBeckerathMMollerCLong-term follow-up in patients treated with curative electrochemotherapy for cancer in the oral cavity and oropharynxActa Otolaryngol20151351070810.3109/00016489.2015.104966326061895Search in Google Scholar

41Granata V, Fusco R, Piccirillo M, Palaia R, Petrillo A, Lastoria S, et al. Electrochemotherapy in locally advanced pancreatic cancer: Preliminary results. Int J Surg 2015; 18: 230–6.GranataVFuscoRPiccirilloMPalaiaRPetrilloALastoriaSElectrochemotherapy in locally advanced pancreatic cancer: Preliminary resultsInt J Surg201518230610.1016/j.ijsu.2015.04.05525917204Search in Google Scholar

42Kreuter A, van Eijk T, Lehmann P, Fischer M, Horn T, Assaf C, et al. Electrochemotherapy in advanced skin tumors and cutaneous metastases - a retrospective multicenter analysis. J Dtsch Dermatol Ges 2015; 13: 308–15.KreuterAvan EijkTLehmannPFischerMHornTAssafCElectrochemotherapy in advanced skin tumors and cutaneous metastases - a retrospective multicenter analysisJ Dtsch Dermatol Ges2015133081510.1111/ddg.1258325819239Search in Google Scholar

43Quaglino P, Matthiessen LW, Curatolo P, Muir T, Bertino G, Kunte C, et al. Predicting patients at risk for pain associated with electrochemotherapy. Acta Oncologica 2015; 54: 298–306.QuaglinoPMatthiessenLWCuratoloPMuirTBertinoGKunteCPredicting patients at risk for pain associated with electrochemotherapyActa Oncologica20155429830610.3109/0284186X.2014.99254625591818Search in Google Scholar

44Mir-Bonafe JM, Vilalta A, Alarcon I, Carrera C, Puig S, Malvehy J, et al. Electrochemotherapy in the treatment of melanoma skin metastases: a report on 31 cases. Actas Dermosifiliogr 2015; 106: 285–91.Mir-BonafeJMVilaltaAAlarconICarreraCPuigSMalvehyJElectrochemotherapy in the treatment of melanoma skin metastases: a report on 31 casesActas Dermosifiliogr20151062859110.1016/j.adengl.2015.03.004Search in Google Scholar

45Campana LG, Mali B, Sersa G, Valpione S, Giorgi CA, Strojan P, et al. Electrochemotherapy in non-melanoma head and neck cancers: a retrospective analysis of the treated cases. Brit J Oral Maxillofac Surg 2014; 52: 957–64.CampanaLGMaliBSersaGValpioneSGiorgiCAStrojanPElectrochemotherapy in non-melanoma head and neck cancers: a retrospective analysis of the treated casesBrit J Oral Maxillofac Surg2014529576410.1016/j.bjoms.2014.08.00425183266Search in Google Scholar

46Ricotti F, Giuliodori K, Cataldi I, Campanati A, Ganzetti G, Ricotti G, et al. Electrochemotherapy: an effective local treatment of cutaneous and subcutaneous melanoma metastases. Dermatol Ther 2014; 27: 148–52.RicottiFGiuliodoriKCataldiICampanatiAGanzettiGRicottiGElectrochemotherapy: an effective local treatment of cutaneous and subcutaneous melanoma metastasesDermatol Ther2014271485210.1111/dth.1209824903471Search in Google Scholar

47Campana LG, Galuppo S, Valpione S, Brunello A, Ghiotto C, Ongaro A, et al. Bleomycin electrochemotherapy in elderly metastatic breast cancer patients: clinical outcome and management considerations. J Cancer Res Clin Oncol 2014; 140: 1557–65.CampanaLGGaluppoSValpioneSBrunelloAGhiottoCOngaroABleomycin electrochemotherapy in elderly metastatic breast cancer patients: clinical outcome and management considerationsJ Cancer Res Clin Oncol201414015576510.1007/s00432-014-1691-624793549Search in Google Scholar

48Seccia V, Muscatello L, Dallan I, Bajraktari A, Briganti T, Ursino S, et al. Electrochemotherapy and its controversial results in patients with head and neck cancer. Anticancer Res 2014; 34: 967–72.SecciaVMuscatelloLDallanIBajraktariABrigantiTUrsinoSElectrochemotherapy and its controversial results in patients with head and neck cancerAnticancer Res20143496772Search in Google Scholar

49Caraco C, Mozzillo N, Marone U, Simeone E, Benedetto L, Di Monta G, et al. Long-lasting response to electrochemotherapy in melanoma patients with cutaneous metastasis. BMC Cancer 2013; 13: 564.CaracoCMozzilloNMaroneUSimeoneEBenedettoLDi MontaGLong-lasting response to electrochemotherapy in melanoma patients with cutaneous metastasisBMC Cancer20131356410.1186/1471-2407-13-564421948024289268Search in Google Scholar

50Campana LG, Bianchi G, Mocellin S, Valpione S, Campanacci L, Brunello A, et al. Electrochemotherapy treatment of locally advanced and metastatic soft tissue sarcomas: Results of a non-comparative phase II study. World J Surg 2014; 38: 813–22CampanaLGBianchiGMocellinSValpioneSCampanacciLBrunelloAElectrochemotherapy treatment of locally advanced and metastatic soft tissue sarcomas: Results of a non-comparative phase II studyWorld J Surg2014388132210.1007/s00268-013-2321-124170155Search in Google Scholar

51Solari N, Spagnolo F, Ponte E, Quaglia A, Lillini R, Battista M, et al. Electrochemotherapy for the management of cutaneous and subcutaneous metastasis: a series of 39 patients treated with palliative intent. J Surg Oncol 2014; 109: 270–4.SolariNSpagnoloFPonteEQuagliaALilliniRBattistaMElectrochemotherapy for the management of cutaneous and subcutaneous metastasis: a series of 39 patients treated with palliative intentJ Surg Oncol2014109270410.1002/jso.2348124165992Search in Google Scholar

52Di Monta G, Caraco C, Benedetto L, La Padula S, Marone U, Tornesello ML, et al. Electrochemotherapy as “new standard of care” treatment for cutaneous Kaposi’s sarcoma. EJSO 2014; 40: 61–6.Di MontaGCaracoCBenedettoLLa PadulaSMaroneUTorneselloMLElectrochemotherapy as “new standard of care” treatment for cutaneous Kaposi’s sarcomaEJSO20144061610.1016/j.ejso.2013.09.00224075826Search in Google Scholar

53Perrone AM, Galuppi A, Cima S, Pozzati F, Arcelli A, Cortesi A, et al. Electrochemotherapy can be used as palliative treatment in patients with repeated loco-regional recurrence of squamous vulvar cancer: a preliminary study. Gynecol Oncol 2013; 130: 550–3.PerroneAMGaluppiACimaSPozzatiFArcelliACortesiAElectrochemotherapy can be used as palliative treatment in patients with repeated loco-regional recurrence of squamous vulvar cancer: a preliminary studyGynecol Oncol2013130550310.1016/j.ygyno.2013.06.02823811116Search in Google Scholar

54Benevento R, Santoriello A, Perna G, Canonico S. Electrochemotherapy of cutaneous metastastes from breast cancer in elderly patients: a preliminary report. BMC Surg 2012; 12 (Suppl 1): S6.BeneventoRSantorielloAPernaGCanonicoSElectrochemotherapy of cutaneous metastastes from breast cancer in elderly patients: a preliminary reportBMC Surg201212(Suppl 1)S610.1186/1471-2482-12-S1-S6349924623173816Search in Google Scholar

55Mevio N, Bertino G, Occhini A, Scelsi D, Tagliabue M, Mura F, et al. Electrochemotherapy for the treatment of recurrent head and neck cancers: preliminary results. Tumori 2012; 98: 308–13.MevioNBertinoGOcchiniAScelsiDTagliabueMMuraFElectrochemotherapy for the treatment of recurrent head and neck cancers: preliminary resultsTumori2012983081310.1177/030089161209800305Search in Google Scholar

56Latini A, Bonadies A, Trento E, Bultrini S, Cota C, Solivetti FM, et al. Effective treatment of Kaposi’s sarcoma by electrochemotherapy and intravenous bleomycin administration. Dermatol Ther 2012; 25: 214–8.LatiniABonadiesATrentoEBultriniSCotaCSolivettiFMEffective treatment of Kaposi’s sarcoma by electrochemotherapy and intravenous bleomycin administrationDermatol Ther201225214810.1111/j.1529-8019.2012.01437.x22741941Search in Google Scholar

57Matthiessen LW, Johannesen HH, Hendel HW, Moss T, Kamby C, Gehl J. Electrochemotherapy for large cutaneous recurrence of breast cancer: a phase II clinical trial. Acta Oncol 2012; 51: 713–21.MatthiessenLWJohannesenHHHendelHWMossTKambyCGehlJElectrochemotherapy for large cutaneous recurrence of breast cancer: a phase II clinical trialActa Oncol2012517132110.3109/0284186X.2012.68552422731832Search in Google Scholar

58Gargiulo M, Papa A, Capasso P, Moio M, Cubicciotti E, Parascandolo S. Electrochemotherapy for non-melanoma head and neck cancers: clinical outcomes in 25 patients. Ann Surg 2012; 255: 1158–64.GargiuloMPapaACapassoPMoioMCubicciottiEParascandoloSElectrochemotherapy for non-melanoma head and neck cancers: clinical outcomes in 25 patientsAnn Surg201225511586410.1097/SLA.0b013e31824f68b222549747Search in Google Scholar

59Curatolo P, Quaglino P, Marenco F, Mancini M, Nardo T, Mortera C, et al. Electrochemotherapy in the treatment of Kaposi sarcoma cutaneous lesions: a two-center prospective phase II trial. Ann Surg Oncol 2012; 19: 192–8.CuratoloPQuaglinoPMarencoFManciniMNardoTMorteraCElectrochemotherapy in the treatment of Kaposi sarcoma cutaneous lesions: a two-center prospective phase II trialAnn Surg Oncol201219192810.1245/s10434-011-1860-721822561Search in Google Scholar

60Kis E, Olah J, Ocsai H, Baltas E, Gyulai R, Kemeny L, et al. Electrochemotherapy of cutaneous metastases of melanoma--a case series study and systematic review of the evidence. Dermatol Surg 2011; 37: 816–24.KisEOlahJOcsaiHBaltasEGyulaiRKemenyLElectrochemotherapy of cutaneous metastases of melanoma--a case series study and systematic review of the evidenceDermatol Surg20113781624Search in Google Scholar

61Skarlatos I, Kyrgias G, Mosa E, Provatopoulou X, Spyrou M, Theodorou K, et al. Electrochemotherapy in cancer patients: first clinical trial in Greece. In Vivo 2011; 25: 265–74.SkarlatosIKyrgiasGMosaEProvatopoulouXSpyrouMTheodorouKElectrochemotherapy in cancer patients: first clinical trial in GreeceIn Vivo20112526574Search in Google Scholar

62Campana LG, Mocellin S, Basso M, Puccetti O, De Salvo GL, Chiarion-Sileni V, et al. Bleomycin-based electrochemotherapy: clinical outcome from a single institution’s experience with 52 patients. Ann Surg Oncol 2009; 16: 191–9.CampanaLGMocellinSBassoMPuccettiODe SalvoGLChiarion-SileniVBleomycin-based electrochemotherapy: clinical outcome from a single institution’s experience with 52 patientsAnn Surg Oncol200916191910.1245/s10434-008-0204-818987914Search in Google Scholar

63Quaglino P, Mortera C, Osella-Abate S, Barberis M, Illengo M, Rissone M, et al. Electrochemotherapy with intravenous bleomycin in the local treatment of skin melanoma metastases. Ann Surg Oncol 2008; 15: 2215–22.QuaglinoPMorteraCOsella-AbateSBarberisMIllengoMRissoneMElectrochemotherapy with intravenous bleomycin in the local treatment of skin melanoma metastasesAnn Surg Oncol20081522152210.1245/s10434-008-9976-018498012Search in Google Scholar

64Larkin JO, Collins CG, Aarons S, Tangney M, Whelan M, O’Reily S, et al. Electrochemotherapy: aspects of preclinical development and early clinical experience. Ann Surg 2007; 245: 469–79.LarkinJOCollinsCGAaronsSTangneyMWhelanMO’ReilySElectrochemotherapy: aspects of preclinical development and early clinical experienceAnn Surg20072454697910.1097/01.sla.0000250419.36053.33187702717435555Search in Google Scholar

65Gaudy C, Richard MA, Folchetti G, Bonerandi JJ, Grob JJ. Randomized controlled study of electrochemotherapy in the local treatment of skin metastases of melanoma. J J Cutan Med Surg 2006; 10: 115–21.GaudyCRichardMAFolchettiGBonerandiJJGrobJJRandomized controlled study of electrochemotherapy in the local treatment of skin metastases of melanomaJ J Cutan Med Surg2006101152110.2310/7750.2006.0003717241586Search in Google Scholar

66Valpione S, Campana LG, Pigozzo J, Chiarion-Sileni V. Consolidation electro-chemotherapy with bleomycin in metastatic melanoma during treatment with dabrafenib. Radiol Oncol 2015; 49: 71–4.ValpioneSCampanaLGPigozzoJChiarion-SileniVConsolidation electro-chemotherapy with bleomycin in metastatic melanoma during treatment with dabrafenibRadiol Oncol20154971410.2478/raon-2014-0035Search in Google Scholar

67Miklavcic D, Corovic S, Pucihar G, Pavselj N. Importance of tumour coverage by sufficiently high local electric field for effective electrochemotherapy. EJC Suppl 2006; 4: 45–51.MiklavcicDCorovicSPuciharGPavseljNImportance of tumour coverage by sufficiently high local electric field for effective electrochemotherapyEJC Suppl20064455110.1016/j.ejcsup.2006.08.006Search in Google Scholar

68Marty M SG, Garbay JR, Gehlc J, Collinsd CG, Snoj M et al. Electrochemotherapy – An easy, highly effective and safe treatment of cutaneous and subcutaneous metastases: Results of ESOPE (European Standard Operating Procedures of Electrochemotherapy) study. EJC Suppl 2006; 4: 3–13.Marty MSGGarbayJRGehlcJCollinsdCGSnojMElectrochemotherapy – Aneasy highly effective and safe treatment of cutaneous and subcutaneous metastases: Results of ESOPE (European Standard Operating Procedures of Electrochemotherapy) studyEJC Suppl2006431310.1016/j.ejcsup.2006.08.002Search in Google Scholar

69Mali B, Miklavcic D, Campana LG, Cemazar M, Sersa G, Snoj M, et al. Tumor size and effectiveness of electrochemotherapy. Radiol Oncol 2013; 47: 32-41.MaliBMiklavcicDCampanaLGCemazarMSersaGSnojMTumor size and effectiveness of electrochemotherapyRadiol Oncol201347324110.2478/raon-2013-0002Search in Google Scholar

70Sersa G, Cemazar M, Semrov D, Miklavcic D. Changing electrode orientation improves the efficacy of electrochemotherapy of solid tumors in mice. Bioelectroch Bioener 1996; 39: 61–6.SersaGCemazarMSemrovDMiklavcicDChanging electrode orientation improves the efficacy of electrochemotherapy of solid tumors in miceBioelectroch Bioener19963961610.1016/0302-4598(95)01866-2Search in Google Scholar

71Miller AB, Hoogstraten B, Staquet M, Winkler A. Reporting results of cancer treatment. Cancer 1981; 47: 207–14.MillerABHoogstratenBStaquetMWinklerAReporting results of cancer treatmentCancer1981472071410.1002/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6Search in Google Scholar

72Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, et al. New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1). Eur J Cancer 2009; 45: 228–47.EisenhauerEATherassePBogaertsJSchwartzLHSargentDFordRNew response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)Eur J Cancer2009452284710.1016/j.ejca.2008.10.026Search in Google Scholar

73Lencioni R, Llovet JM. Modified RECIST (mRECIST) assessment for hepato-cellular carcinoma. Semin Liver Disease 2010; 30: 52–60.LencioniRLlovetJMModified RECIST (mRECIST) assessment for hepato-cellular carcinomaSemin Liver Disease201030526010.1055/s-0030-1247132Search in Google Scholar

74Choi JH, Ahn MJ, Rhim HC, Kim JW, Lee GH, Lee YY, et al. Comparison of WHO and RECIST criteria for response in metastatic colorectal carcinoma. Cancer Res Treat 2005; 37: 290–3.ChoiJHAhnMJRhimHCKimJWLeeGHLeeYYComparison of WHO and RECIST criteria for response in metastatic colorectal carcinomaCancer Res Treat200537290310.4143/crt.2005.37.5.290Search in Google Scholar

75Goldberg SN, Grassi CJ, Cardella JF, Charboneau JW, Dodd GD, Dupuy DE, et al. Image-guided tumor ablation: Standardization of terminology and reporting criteria. J Vasc Interv Radiol 2009; 20: S377-S90.GoldbergSNGrassiCJCardellaJFCharboneauJWDoddGDDupuyDEImage-guided tumor ablation: Standardization of terminology and reporting criteriaJ Vasc Interv Radiol200920S377S9010.1016/j.jvir.2009.04.011Search in Google Scholar

76Callstrom MR, York JD, Gaba RC, Gemmete JJ, Gervais DA, Millward SF, et al. Research reporting standards for image-guided ablation of bone and soft tissue tumors. J Vasc Interv Radiol 2009; 20: 1527–40.CallstromMRYorkJDGabaRCGemmeteJJGervaisDAMillwardSFResearch reporting standards for image-guided ablation of bone and soft tissue tumorsJ Vasc Interv Radiol20092015274010.1016/j.jvir.2009.08.00919864161Search in Google Scholar